Lantern Pharma (LTRN) Reports Q2 Loss of $0.31

Go back to Lantern Pharma (LTRN) Reports Q2 Loss of $0.31
(NASDAQ: LTRN) Delayed: 1.58 +0.03 (1.94%)
Previous Close $1.55    52 Week High
Open $1.59    52 Week Low
Day High $1.63    P/E N/A 
Day Low $1.53    EPS
Volume 56,702